These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17556309)

  • 1. Cardiovascular risk factors in peritoneal dialysis patients revisited.
    Wang AY
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S223-7. PubMed ID: 17556309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The "heart" of peritoneal dialysis.
    Wang AY
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S228-32. PubMed ID: 17556310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for improving long-term survival in peritoneal dialysis patients.
    Kendrick J; Teitelbaum I
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1123-31. PubMed ID: 20430945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal dialysis and cardiovascular disease.
    Balafa O; Krediet RT
    Minerva Urol Nefrol; 2012 Sep; 64(3):153-62. PubMed ID: 22971680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of chronic inflammation in peritoneal dialysis.
    Wang AY
    Semin Nephrol; 2011 Mar; 31(2):159-71. PubMed ID: 21439430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The John F. Maher Award Recipient Lecture 2006. The "heart" of peritoneal dialysis: residual renal function.
    Wang AY
    Perit Dial Int; 2007; 27(2):116-24. PubMed ID: 17299143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Hemodialysis and Peritoneal Dialysis in Patients with Cardiovascular Disease.
    Albakr RB; Bargman JM
    Cardiol Clin; 2021 Aug; 39(3):447-453. PubMed ID: 34247757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypervolemia, hypoalbuminemia and mitral calcification as markers of cardiovascular risk in peritoneal dialysis patients.
    Querido S; Quadros Branco P; Silva Sousa H; Adragão T; Araújo Gonçalves P; Gaspar MA; Barata JD
    Rev Port Cardiol; 2017 Sep; 36(9):599-604. PubMed ID: 28843932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Rhythm Complexity Predicts Long-Term Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective Cohort Study.
    Tsai CH; Huang JW; Lin C; Ma HP; Lo MT; Liu LD; Lin LY; Lin CT; Hung CS; Peng CK; Lin YH
    J Am Heart Assoc; 2020 Jan; 9(2):e013036. PubMed ID: 31910780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is peritoneal dialysis associated with increased cardiovascular morbidity and mortality?
    Van Biesen W; Vanholder R; Verbeke F; Lameire N
    Perit Dial Int; 2006; 26(4):429-34. PubMed ID: 16881336
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelial function in pediatric patients on peritoneal dialysis: the need for data.
    Lilien MR; Schröder CH; Koomans HA
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S127-9. PubMed ID: 16048277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients.
    Li PK; Chow KM
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S80-3. PubMed ID: 16048264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients.
    Jegatheesan D; Cho Y; Johnson DW
    Semin Nephrol; 2018 May; 38(3):277-290. PubMed ID: 29753403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling inflammation in peritoneal dialysis: the role of pd-related factors as potential intervention targets.
    Fortes PC; Versari PH; Stinghen AE; Pecoits-Filho R
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S76-81. PubMed ID: 17556335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of preserving residual renal function in peritoneal dialysis.
    Marrón B; Remón C; Pérez-Fontán M; Quirós P; Ortíz A
    Kidney Int Suppl; 2008 Apr; (108):S42-51. PubMed ID: 18379546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?
    Papakrivopoulou E; Lillywhite S; Davenport A
    Nephrol Dial Transplant; 2012 Jan; 27(1):396-401. PubMed ID: 21765049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular issues in dialysis patients: challenges and newer insights.
    Guzon OJ; Dellsperger KC
    Adv Perit Dial; 2006; 22():111-5. PubMed ID: 16983952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk in the peritoneal dialysis patient.
    Krediet RT; Balafa O
    Nat Rev Nephrol; 2010 Aug; 6(8):451-60. PubMed ID: 20567248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
    Kuhlmann MK
    Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical epidemiology of major nontraditional risk factors in peritoneal dialysis patients.
    Zoccali C; Enia G; Tripepi G; Panuccio V; Mallamaci F
    Perit Dial Int; 2005 Feb; 25 Suppl 3():S84-7. PubMed ID: 16048265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.